重组蛋白质纯化技术

90年代以来 ,基因重组技术得到很大的发展 ,基因工程产品的分离纯化的成本约占其全部成本的 6 0 %～ 80 %,因此重组蛋白的分离纯化技术越来越重要。着重介绍了扩张柱床吸附层析技术 ,径向膜层析技术 ,灌注层析技术 ,液液萃取技术 ,置换层析技术和金属螯合亲和层析技术近年来进展情况以及它们的优缺点和应用范围。     

CaMBP-10的cDNA克隆和表达及钙调素结合活性分析

采用RT PCR法 ,从中国大白菜中分离了编码CaMBP 1 0的cDNA克隆 .该cDNA全长 4 96bp ,编码 92个氨基酸 ,3′端含有 2 1 6bp的非编码区和poly A尾 .将此BP 1 0cDNA的成熟蛋白序列导入表达质粒pET1 5b并转化至大肠杆菌E .coliBL2 1 (DE3)condonplus RIL进行表达 .以免疫印迹和钙调素结合分析法对重组BP 1 0进行鉴定 ,证明其保持了与天然BP 1 0相同的钙调素结合活性 .氨基酸和核苷酸序列分析结果显示 ,它与植物转脂蛋白高度同源 ,特别是含有 8个保守半胱氨酸 .BP 1 0与转脂蛋白之间具极为相似的理化性质如分子量、等电点、热稳定性等 .据此认为 ,CaMBP 1 0是转脂蛋白家族的新成员 ,Ca2 + CaM信号系统可能参与植物转脂蛋白功能的调节     

重组胸腺素α1的纯化及活性

将胸腺素α1基因4串体克隆于pThioHisA融合表达载体(pThioHisA-Tα1④),转化大肠杆菌TOP10。在IPTG诱导下,融合蛋白得到了高效表达。SDS-PAGE分析确定诱导表达的融合蛋白占菌体总蛋白的40%,且表达的融合蛋白主要以可溶形式存在。把用离子交换层析纯化出的目的蛋白进行CNBr化学裂解,经简单的离子交换层析可纯化出胸腺素α1单体,HPLC鉴定胸腺素α1的纯度达98%。利用3H-TdR进行生物活性测定,证实融合蛋白和胸腺素α1单体均具有在致有丝分裂原ConA存在的条件下,刺激小鼠脾淋巴细胞分裂增殖的能力,与化学合成的胸腺素α1相比具有相似的生物活性。     

“蛋白质与酶工程”教学的课程思政探索与实践

蛋白质与酶工程是生物技术专业的核心、必修课程,在专业人才培养体系中具有重要地位。文中以教育部颁布的《高等学校课程思政建设指导纲要》为依据、结合专业及课程特色,科学设定教学目标,深入挖掘课程思政教育元素,从融入内容、方法路径及评价等方面进行了课程思政教学改革的探索和实践。通过精心开展教学设计,利用对分课堂、以学生为中心,从讲故事、谈生活、说案例、议热点、读文献、做训练入手,激发并培养学生的科学精神、公民品格、全球视野、生态文明、法治意识、家国情怀和文化自信素养,促进课程思政教育有机融入教学全过程,实现课程育人目标的同时推动教学卓越。     

银耳二型态细胞差异性的初步研究

以银耳的担孢子、节孢子和菌丝体为材料,通过显微观察和电泳分析揭示银耳二型态细胞间的差异性。显微形态及核相观察表明:节孢子直径略大于担孢子,担孢子为单核细胞,节孢子绝大多数为单核细胞,少数为双核细胞,菌丝体为双核细胞并具有典型的锁状联合结构。总蛋白及同工酶电泳分析表明:菌丝相总蛋白谱带多于酵母相,过氧化物及酯酶与酵母相存在一定差异,而多酚氧化酶基本相同。因此,伴随银耳二型态细胞两相形态的转变,细胞代谢水平发生了相应变化。     

脊髓全横断损伤后差异表达蛋白的蛋白质组学分析

 对脊髓全横断损伤前后的大鼠脊髓全蛋白质进行双向凝胶电泳,借助PDQuest软件从中找出差异表达蛋白质点.应用基质辅助激光解吸电离串联质谱,对差异表达的蛋白质点进行鉴定,成功鉴定出18种蛋白质.脊髓损伤3 d后表达上调的蛋白质有巨噬细胞游走抑制因子、S期激酶相关蛋白 1、热休克蛋白 27、多配体蛋白聚糖 3、T细胞受体β链可变区、膜联蛋白Ⅲ、腺苷酸激酶 1、半乳凝素 3、丙酮酸脱氢酶、磷脂酶 B、嗜铬粒蛋白 A、热休克蛋白70凝结蛋白 1;同时表达下调的蛋白质有磷酸丙糖异构酶、神经鞘氨醇磷酸化受体、热休克蛋白10、肽酰 脯氨酰 顺反式异构酶 A多数差异蛋白质涉及到神经细胞的增殖、凋亡、应激反应等过程,为进一步阐明中枢神经系统的损伤和修复机制提供了理论依据.摘要 对脊髓全横断损伤前后的大鼠脊髓全蛋白质进行双向凝胶电泳,借助PDQuest软件从中找出差异表达蛋白质点.应用基质辅助激光解吸电离串联质谱,对差异表达的蛋白质点进行鉴定,成功鉴定出18种蛋白质.脊髓损伤3 d后表达上调的蛋白质有巨噬细胞游走抑制因子、S期激酶相关蛋白 1、热休克蛋白 27、多配体蛋白聚糖 3、T细胞受体β链可变区、膜联蛋白Ⅲ、腺苷酸激酶 1、半乳凝素 3、丙酮酸脱氢酶、磷脂酶 B、嗜铬粒蛋白 A、热休克蛋白70凝结蛋白 1;同时表达下调的蛋白质有磷酸丙糖异构酶、神经鞘氨醇磷酸化受体、热休克蛋白10、肽酰 脯氨酰 顺反式异构酶 A多数差异蛋白质涉及到神经细胞的增殖、凋亡、应激反应等过程,为进一步阐明中枢神经系统的损伤和修复机制提供了理论依据.     

Structure of Novel Enzyme in Mannan Biodegradation Process 4-O-β-d-Mannosyl-d-Glucose Phosphorylase MGP

The crystal structure of a novel component of the mannan biodegradation system, 4-O-β-d-mannosyl-d-glucose phosphorylase (MGP), was determined to a 1.68-Å resolution. The structure of the enzyme revealed a unique homohexameric structure, which was formed by using two helices attached to the N-terminus and C-terminus as a tab for sticking between subunits. The structures of MGP complexes with genuine substrates, 4-O-β-d-mannosyl-d-glucose and phosphate, and the product d-mannose-1-phosphate were also determined. The complex structures revealed that the invariant residue Asp131, which is supposed to be the general acid/base, did not exist close to the glycosidic Glc-O4 atom, which should be protonated in the catalytic reaction. Also, no solvent molecule that might mediate a proton transfer from Asp131 was observed in the substrate complex structure, suggesting that the catalytic mechanism of MGP is different from those of known disaccharide phosphorylases.     

PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone

In vivo and in vitro studies have suggested a neuroprotective role for Pituitary adenylate cyclase activating polypeptide (PACAP) against neuronal insults. Here, we showed that PACAP27 protects against neurotoxicity induced by rotenone, a mitochondrial complex I inhibitor that has been implicated in the pathogenesis of Parkinson's disease (PD). The neuroprotective effect of PACAP27 was dose-dependent and blocked by its specific receptor antagonist, PACAP6-27. The effects of PACAP27 on rotenone-induced cell death were mimicked by dibutyryl-cAMP (db-cAMP), forskolin and prevented by the PKA inhibitor H89, the ERK inhibitor PD98059 and the p38 inhibitor SB203580. PACAP27 administration blocked rotenone-induced increases in the level of caspase-3-like activity, whereas could not restore mitochondrial activity damaged by rotenone. Thus, our results demonstrate that PACAP27 has a neuroprotective role against rotenone-induced neurotoxicity in neuronal differentiated PC12 cells and the neuroprotective effects of PACAP are associated with activation of MAP kinase pathways by PKA and with inhibition of caspase-3 activity; the signaling mechanism appears to be mediated through mitochondrial-independent pathways.